Spencer David M.

Avg. Two Year Performance

No purchase track record

70% Avg. Sale Return

31% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	15%	22%	36%	47%	70%
Sale Success Rate	9 of 10	8 of 10	10 of 10	10 of 10	10 of 10

Bellicum Pharmaceuticals, Inc

Drugs » Biotechnology

Chief Technology Officer:

Holdings: 92.47K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--